Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | AXL | P30530 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.33 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.33 |
| ▸ | FABP4 | P15090 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9392467 | 0.82 | KDM4E (0.31) | MAPTKDM4EPOLBHPGD | |
| SCHEMBL179502 | 0.78 | — | — | |
| SCHEMBL19059659 | 0.74 | ALDH1A1 (0.31) | — | |
| SCHEMBL18214809 | 0.74 | — | — | |
| SCHEMBL2161282 | 0.73 | NPSR1 (0.33) | HSP90AA1HSP90AB1 | |
| Hydrochloric Acid SCHEMBL28561916 | 0.73 | HPGD (0.33) | HSP90AA1HSP90AB1MAPTKDM4EHPGD | |
| SCHEMBL22541579 | 0.73 | HSP90AA1 (0.31) | HSP90AA1HSP90AB1 | |
| SCHEMBL25791857 | 0.71 | NT5E (0.32) | KDM4E | |
| SCHEMBL26500656 | 0.71 | — | — | |
| SCHEMBL9981270 | 0.71 | TRPV4 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113745539-B | Fluorine-containing non-noble metal oxygen reduction electrocatalyst and preparation method and application thereof | 大连理工大学 | 2022-11-22 | — | — | CN | claimed |
| CN-113745539-A | Fluorine-containing non-noble metal oxygen reduction electrocatalyst and preparation method and application thereof | 大连理工大学 | 2021-12-03 | — | — | CN | claimed |
| CN-102698819-B | Deacidification agent applied to methyl tert-butyl ether (MTBE) production device and preparation method for deacidification agent | KAIRUI CHEMICAL CO LTD | 2014-02-19 | — | — | CN | claimed |
| CN-103224535-A | Metal or ligand replacement method for construction of mixed metal or mixed ligand zeolitic imidazolate frameworks (ZIFs) | DALIAN CHEMICAL PHYSICS INST | 2013-07-31 | — | — | CN | claimed |
| CN-102698819-A | Deacidification agent applied to methyl tert-butyl ether (MTBE) production device and preparation method for deacidification agent | KAIRUI CHEMICAL CO LTD | 2012-10-03 | — | — | CN | claimed |
| JP-2002517459-A | — | — | 2002-06-18 | — | — | JP | claimed |
| JP-2002517460-A | — | — | 2002-06-18 | — | — | JP | claimed |
| EP-1019075-A4 | $g(b)2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE INC (US) | 2000-12-13 | — | — | EP | claimed |
| EP-1019360-A1 | $g(b)2-ADRENERGIC RECEPTOR AGONISTS | Advanced Medicine, Inc. (US) | 2000-07-19 | — | — | EP | claimed |
| EP-1019075-A1 | $g(b)2-ADRENERGIC RECEPTOR AGONISTS | Advanced Medicine, Inc. (US) | 2000-07-19 | — | — | EP | claimed |
| EP-1019360-A4 | $g(b)2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE INC (US) | 2000-07-19 | — | — | EP | claimed |
| WO-1999064035-A9 | β2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE INC (US) | 2000-07-06 | — | — | WO | claimed |
| WO-1999064034-A9 | β2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE INC (US) | 2000-06-29 | — | — | WO | claimed |
| WO-1999064031-A9 | β2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE INC (US) | 2000-05-04 | — | — | WO | claimed |
| WO-1999064034-A1 | β2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | claimed |
| WO-1999064035-A1 | β2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | claimed |
| US-20240327410-A1 | Monoacylglycerol Lipase Modulators | JANSSEN PHARMACEUTICA NV (BE) | 2024-10-03 | — | — | US | disclosed |
| US-20240246960-A1 | 7-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2024-07-25 | — | — | US | disclosed |
| WO-1999064031-A1 | β2-ADRENERGIC RECEPTOR AGONISTS | ADVANCED MEDICINE, INC. (US) | 1999-12-16 | — | — | WO | disclosed |
| WO-1994021606-A1 | PENTAFLUOROSULPHANYLPHENYL AND PENTAFLUOROSULPHANYLPYRIDIL SUBSTITUTED HETEROAROMATIC COMPOUNDS WITH INSECTICIDAL OR ACARICIDAL ACTIVITY | ZENECA LIMITED (GB) | 1994-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240246960-A1 | 7-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK Inhibitor | DCK, ERCC2, POLK | HSP90AA1 1901/4885HSP90AB1 1551/4885MAPT 4225/4885 |
| US-20240327410-A1 | Monoacylglycerol Lipase Modulators | MGLL, LPL, PNLIP | HSP90AA1 2117/4885HSP90AB1 1909/4885MAPT 2188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.